Key result
Warfarin linked to fatal late-onset skin necrosis and septic shock in a recent case report.
Case Report (n=1)
Highlights a rare and fatal case of late-onset warfarin-induced skin necrosis occurring 56 days after initiation.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible late-onset warfarin necrosis beyond 8 weeks; single case leaves open risk factor identification.
A 43-year-old woman developed tenderness and induration of her thighs and lower abdomen, 56 days after commencing warfarin for aortic and mitral valve replacements. Investigations showed elevated inflammatory markers, mild renal impairment, normal echocardiogram and low protein C and S levels consistent with warfarin therapy. Three weeks later, purpuric areas evolved into large tender haemoserous bullae, which broke down to form ulcers. Histology confirmed the clinical impression of warfarin-induced skin necrosis with dermal and subcutaneous venular thrombi. Despite cessation of warfarin and commencement of heparin, the lesions progressed. When the patient became febrile, blood cultures grew Pseudomonas aeruginosa, which was treated with intravenous imipenem and vancomycin. Wound swabs grew methycillin-resistant Staphylococcus aureus and the antibiotics were changed. The patient developed septic shock and, despite intensive care management, her condition deteriorated and she died 9 weeks after the onset of the skin symptoms.
No takes yet. Share an insight, caveat, or question.
Scarff et al. (2002) conducted a case report in Late-onset warfarin necrosis (n=1). Warfarin was evaluated on Development of warfarin-induced skin necrosis and clinical course. Warfarin therapy resulted in fatal late-onset skin necrosis complicated by septic shock 56 days after initiation for valve replacements in a 43-year-old woman.
Synapse has enriched 10 related papers. Consider them for comparative context: